The predicted increase would be driven by sustained high prices for raw materials, freight and shipping costs and the effects of tariffs on medical-surgical products manufactured in China, according to a news release from the healthcare performance improvement company.
Key items affected include gloves, needles, syringes and face masks. Enteral syringes will also see an impact from tariffs set to take effect in 2026, although Vizient said in the release that it helped delay the tariffs’ implementation, giving manufacturers time to diversify production outside of China.
In addition to med-surg products, other areas are expected to see cost increases, including construction, water services and medical gases.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
